WeVote
Log In

Bill

Bill

SB 803

AN ACT EXPANDING ACCESS TO OUTPATIENT SUBSTANCE ABUSE TREATMENT BY REDUCING REGULATORY BURDENS ON PROVIDERS.

2025 Regular Session Introduced by Christine Cohen and 1 co-sponsor

Connecticut bill reduces regulatory requirements on outpatient substance abuse treatment providers to expand treatment access and capacity statewide.

PUBLIC HEARING 0220
#drugabusetreatment #outpatientclinics
0
WeVote Research Nonpartisan
Bill Summary · SB 803

Legislative bill overview

SB 803 seeks to expand access to outpatient substance abuse treatment services in Connecticut by reducing regulatory requirements and compliance burdens on treatment providers. The bill aims to streamline licensing, operational, or reporting requirements that currently limit the ability of providers to offer or expand outpatient treatment programs.

Why is this important

Connecticut, like most states, faces significant gaps in substance abuse treatment capacity, with long waitlists and limited outpatient options. Reducing regulatory barriers could enable existing providers to expand services and allow new providers to enter the market more easily, potentially increasing treatment access during a period of ongoing opioid and addiction crises.

Potential points of contention

  • Quality and safety standards: Opponents may argue that reducing regulations could compromise patient safety, quality of care standards, or accountability if regulations exist to protect vulnerable populations in treatment
  • Scope of deregulation: Disagreement over which specific regulations should be eliminated—excessive cuts could undermine oversight while minimal changes may not meaningfully expand access
  • Unequal provider impact: Smaller or new providers may benefit more than established ones, potentially creating market disruption or competitive concerns among existing treatment organizations

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.